GL1X · GenesisL1 explorer

Research workbench

Structure of human TRIP13, apo form

Analyse Structure of human TRIP13, apo form in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5VQ9
Type
protein
Length
367 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pachytene checkpoint protein 2 homolog
UniProt
Q15645
Pockets
5 · best druggability 0.48

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
DPachytene checkpoint protein 2 homologprotein36746% helix, 17% strandQ15645

Pockets

5 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11150.480.7920empty
21000.480.8119empty
31220.480.7922empty
41110.450.7819empty
51540.410.7424empty

Compared structures

  • 5VQ9 · Structure of human TRIP13, Apo form · the same entry in another collection · chain D against D, TM-score 1.00
  • Q15645 · AlphaFold monomer V2.0 prediction for pachytene checkpoint protein 2 homolog (Q15645) · a predicted model of the same protein · chain D against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.